Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2008
12/31/2008CN100447156C T2R taste receptors and genes encoding same
12/31/2008CA2694120A1 Method of discovering and analyzing secreted biomarkers of disease from solid tissue
12/31/2008CA2692332A1 Method for detection or treatment of graft versus host disease
12/31/2008CA2692171A1 Methods and uses thereof of prosaposin
12/31/2008CA2692112A1 Method for screening for selective modulator of the nf-kb pathway activation
12/31/2008CA2691755A1 Recombinant north american type 1 porcine reproductive and respiratory syndrome virus and methods of use
12/31/2008CA2691572A1 Sample plate
12/31/2008CA2691568A1 Sample plate
12/31/2008CA2691200A1 Method for optimizing the treatment of chronic myeloid leukemia with abl tyrosine kinase inhibitors
12/31/2008CA2691191A1 Exposure system
12/31/2008CA2690943A1 Conjugates containing hydrophilic spacer linkers
12/31/2008CA2690904A1 Lateral flow assay system and methods for its use
12/31/2008CA2690888A1 Cancer therapeutic composition comprising antibody against peptide encoded by exon-17 site of periostin
12/31/2008CA2689318A1 Method for determining the sensitive or insensitive nature of a hexogen
12/31/2008CA2689064A1 Sequence based engineering and optimization of single chain antibodies
12/30/2008US7472050 Method and apparatus for computer modeling a joint
12/30/2008US7471394 Optical detection system with polarizing beamsplitter
12/30/2008US7470962 Field effect transistor for measuring biocomponents
12/30/2008US7470783 Performing photochemical reactions on a surface; prepare chemical mixture, apply to surface, irradiate, monitor generation of reaction product; Blocking; high density arrays; activation
12/30/2008US7470782 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions
12/30/2008US7470775 Anti-CD30 stalk and anti-CD30 antibodies suitable for use in immunotoxins
12/30/2008US7470774 Anti-pro1477 antibodies
12/30/2008US7470773 Monoclonal antibodies for binding immunoglobins
12/30/2008US7470721 Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways
12/30/2008US7470698 Adenosine A3 receptor modulators
12/30/2008US7470673 Using vector comprising nucleotide sequences coding atonal-associated polypetides as therapeutic tool in treating hearing impairment and inflammatory bone disorders; antiarthritic agents
12/30/2008US7470662 Method of reducing the likelihood of implantation failure during an assisted reproduction in a female subject in a need thereof
12/30/2008US7470550 Using surface plasmon resonance analyzer to monitor physiological response of immobilized cells to external stimuli; in vitro drug testing and screening
12/30/2008US7470549 Measurement method using biosensor
12/30/2008US7470548 Hazardous substance removing method, hazardous substance removing material used therein such as air filter, mask, wipe sheet, and the like, and storage method thereof
12/30/2008US7470545 Apparatus for use in oral detection of preferential particles
12/30/2008US7470543 High throughput assay which utilizes nuclear magnentic resonance to identify modulators of protein binding activities
12/30/2008US7470542 based on the finding that fifteen proteins surprisingly were either down- or up-regulated in type 2-diabetes; Eleven of these proteins (markers for type 2 diabetes) were positively identified by mass spectrometry
12/30/2008US7470540 Using immobilized particles to biosynthesize and quantify polymeric receptors; for use as diagnostic and bioscience tools
12/30/2008US7470536 Transgenic cell line for use as tools in identification of signal transduction modulators; diagnostic assay comprising enhanced shelf life
12/30/2008US7470519 based in part on the discovery that potato carboxypeptidase inhibitor (PTCI) binds to both TAFIa and TAFIai but not to the 60 kD proenzyme form of TAFI nor to the N-terminal activation peptide of TAFI
12/30/2008US7470518 Systems and method for rapidly changing the solution environment around sensors
12/30/2008US7470514 Using expression level of prostate specific genes as diagnostic/prognostic tool in detection and classification of cell proliferative disorders
12/30/2008US7470513 Correlating presence of preferential human leukocyte antigen allele and negative drug response to allopurinol; haplotyping
12/30/2008US7470510 Methods for diagnosing cancer and determining a susceptibility for developing cancer
12/30/2008US7470509 Compositions and methods for the identification, assessment, prevention and therapy of ovarian cancer
12/30/2008US7470508 Screening for melanoma in skin sample; obtain skin extract nucleotide sequences, incubate with cyclin sequence probe, determine concentration of bound probe, compare to control, evaluate for skin melanoma
12/30/2008US7470506 Fitness assay and associated methods
12/30/2008US7470432 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease
12/30/2008US7470404 Fluid sample collection and isolation cup
12/30/2008US7470400 Sensor cartridge, sensor feeder, and measuring instrument
12/30/2008US7470397 Disintegratable films for diagnostic devices
12/30/2008US7470379 Inorganic particle conjugates
12/30/2008US7470371 Centrifuging whole blood with a float in the cavity that has a density between the erythrocytes and plasma and moves through the sedimenting erythrocytes during centrifugation and releases trapped platelets
12/30/2008US7470352 Sensor arrangement
12/30/2008US7469836 Hand-held laser scanning device for scanning a product item
12/30/2008US7469799 Measurement instrument
12/30/2008US7469608 Dissolution tester
12/30/2008US7469589 Method and device for determining the limpness of sheet material by means of ultra-sound
12/30/2008US7469574 Liquid type identifying method and liquid type identifying device
12/30/2008CA2492865C Microfluidic devices, methods, and systems
12/30/2008CA2440635C System for optimising the production performance of a milk producing animal herd
12/30/2008CA2391293C .beta.2-adrenergic receptor agonists
12/30/2008CA2387836C Apparatus for intestinal sampling and use thereof
12/30/2008CA2330646C Method for determining deleterious bacterial growth in packaged food utilizing hydrophilic polymers
12/30/2008CA2263816C Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity
12/30/2008CA2229558C Mono-allelic mutation analysis for identifying germline mutations
12/30/2008CA2216895C Method for instrument determination of a measured variable which changes with time
12/30/2008CA2117612C Periplasmic membrane-bound system for detecting protein-protein interactions
12/30/2008CA2113744C Methods for regulating the immune response using ctla4-binding molecules and il4-binding molecules
12/27/2008CA2635465A1 Systems and methods for mapping binding site volumes in macromolecules
12/25/2008US20080320388 Gene information display method and apparatus
12/25/2008US20080319685 Systems and Methods For Measuring Multiphase Flow in a Hydrocarbon Transporting Pipeline
12/25/2008US20080319680 Multi-gain adaptive linear processing and gated digital system for use in flow cytometry
12/25/2008US20080319679 Systems and methods for analyzing microarrays
12/25/2008US20080319678 Mass Tagging for Quantitative Analysis of Biomolecules using 13C Labeled Phenylisocyanate
12/25/2008US20080319676 Absolute Quantitation of Protein Contents Based on Exponentially Modified Protein Abundance Index by Mass Spectrometry
12/25/2008US20080319560 Automated recipe composer
12/25/2008US20080319291 Blood Testing Apparatus Having a Rotatable Cartridge with Multiple Lancing Elements and Testing Means
12/25/2008US20080319287 Implantable Power Sources and Sensors
12/25/2008US20080319179 A nucleotide having a base attached to a detectable label through a cleavable linker; has a deoxyribose comprising a cleavable chemical group capping the 3' OH group of the deoxyribose and wherein both the cleavable linker and the capping cleavable chemical group are cleavable by light
12/25/2008US20080319176 Glycerol as a predictor of glucose tolerance
12/25/2008US20080319165 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least one neuropeptide
12/25/2008US20080318959 using 3-amino-5-ethyl-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide
12/25/2008US20080318872 Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof
12/25/2008US20080318868 Use of Mycobacterial Mannosylated Lipoglycans Peptide Mimotopes For Treating Inflammation
12/25/2008US20080318857 Compositions and Methods for the Intracellular Disruption of Vegf and Vegfr-2 By Intraceptors
12/25/2008US20080318853 Diagnostic and Therapeutic Use of a Novel Growth Factor, Neublasmin
12/25/2008US20080318851 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
12/25/2008US20080318836 sCD Fingerprints
12/25/2008US20080318835 Novel Integrin Ligand ITGL-TSP
12/25/2008US20080318806 Device for chemical and biochemical reactions using photo-generated reagents
12/25/2008US20080318802 Methods and compositions for tagging and identifying polynucleotides
12/25/2008US20080318798 Antigen Detection
12/25/2008US20080318342 Diagnostic Testing Process and Apparatus Incorporating Controlled Sample Flow
12/25/2008US20080318341 Dual Path Immunoassay Device
12/25/2008US20080318340 Method of Detecting Target Substances
12/25/2008US20080318339 Sensing Device and Method For Determination of Teh Amount of Target Molecule in an Analyte
12/25/2008US20080318338 Drug screening using a high affinity form of Heat Shock Protein-90 (HSP90) that has a 17-allylamino-geldanamycin (17-AAG) binding affinity
12/25/2008US20080318337 Method for Determining a Tissue Degradation Process by Detection of Comp Neoepitopes
12/25/2008US20080318333 Method and System for Measurement of Nitrite and Nitric Oxide Release
12/25/2008US20080318332 Disease diagnosis by profiling serum glycans
12/25/2008US20080318331 Anthraquinone Derivatives as Markers For Liquids
12/25/2008US20080318330 Method of standardization of bacterial polysaccharides found in rumen fluid
12/25/2008US20080318329 Liquid crystal condensation of nucleic acid (na) complexes